Ulrich Laufs, Germany
TBA TBA
Presenter of 7 Presentations
On the horizon: Novel options for the combination of LDL-C lowering therapies
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
16:00 - 17:30
Lecture Time
16:40 - 16:55
[{"name":"On the horizon: Novel options for the combination of LDL-C lowering therapies","mode":"playlist","public":true,"info":{"id":1742,"presentation":"On the horizon: Novel options for the combination of LDL-C lowering therapies","session":"Not included in the main CME-CPD of the event","presenter":"Ulrich Laufs, Germany","photo":""},"playlist":[{"name":"On the horizon: Novel options for the combination of LDL-C lowering therapies","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Video 4 - EAS Virtual Congress - Prof Laufs.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Video 4 - EAS Virtual Congress - Prof Laufs.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/B0432A0C.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0w3"}
[session]
[presentation]
[presenter]
Panel discussion & Conclusion
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
16:00 - 17:30
Lecture Time
16:55 - 17:30
[{"name":"Panel discussion & Conclusion","mode":"playlist","public":true,"info":{"id":1743,"presentation":"Panel discussion & Conclusion","session":"Not included in the main CME-CPD of the event","presenter":"Alberico Luigi Catapano, Italy, Fran\u00e7ois Mach, Switzerland, Ulrich Laufs, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Add on to take back control Combining lipid-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Add on to take back control Combining lipid-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/EDE0A2.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Xi0w4"}
[session]
[presentation]
[presenter]
How did the ESC/EAS guidelines change my practice?
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
14:30 - 16:00
Lecture Time
15:00 - 15:12
[{"name":"How did the ESC\/EAS guidelines change my practice?","mode":"playlist","public":true,"info":{"id":1747,"presentation":"How did the ESC\/EAS guidelines change my practice?","session":"Not included in the main CME-CPD of the event","presenter":"Ulrich Laufs, Germany","photo":""},"playlist":[{"name":"How did the ESCEAS guidelines change my practice","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/Laufs EAS20 How did the ESCEAS guidelines change my practice.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/111\/Laufs EAS20 How did the ESCEAS guidelines change my practice.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/AF47C85.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0w8"}
[session]
[presentation]
[presenter]
LIVE Panel discussion: with a focus on very-high risk patients
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
14:30 - 16:00
Lecture Time
15:28 - 15:53
[{"name":"LIVE Panel discussion: with a focus on very-high risk patients","mode":"playlist","public":true,"info":{"id":1749,"presentation":"LIVE Panel discussion: with a focus on very-high risk patients","session":"Not included in the main CME-CPD of the event","presenter":"Fran\u00e7ois Mach, Switzerland, Kausik K. Ray, United Kingdom, Chris Packard, United Kingdom, Ulrich Laufs, Germany, Pasquale P. Filardi, Italy","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/Targeting PCSK9.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/111\/Targeting PCSK9.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/4F94738A.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0wa"}
[session]
[presentation]
[presenter]
When do we need add on therapies to statin?
Session Time
17:00 - 18:30
Lecture Time
17:17 - 17:31
[{"name":"When do we need add on therapies to statin?","mode":"playlist","public":true,"info":{"id":1506,"presentation":"When do we need add on therapies to statin?","session":"Novel approaches to lipid lowering management","presenter":"Ulrich Laufs, Germany","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/Ulrich Laufs - EAS20-1506-When Do We Need Add on Therapies to Statin.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/105\/Ulrich Laufs - EAS20-1506-When Do We Need Add on Therapies to Statin.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/7EA9942E.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0rY"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Session Time
17:00 - 18:30
Lecture Time
17:45 - 18:00
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1581,"presentation":"Panel Discussion with Live Q&A","session":"Novel approaches to lipid lowering management","presenter":"Marja-Riitta Taskinen, Finland, Alberico Luigi Catapano, Italy, Lale Tokg\u00f6zo\u011flu, Turkey, Ulrich Laufs, Germany, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5369.jpg"},"playlist":[{"name":"Novel approaches to lipid lowering management","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/Novel approaches to lipid lowering management.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/105\/Novel approaches to lipid lowering management.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/D568E245.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0tg"}
[session]
[presentation]
[presenter]
Management of stable coronary heart disease patients
Session Type
Track 1 - Advanced clinical seminar
Session Time
11:30 - 12:00
Lecture Time
11:33 - 11:43
[{"name":"Management of stable coronary heart disease patients","mode":"playlist","public":true,"info":{"id":1448,"presentation":"Management of stable coronary heart disease patients","session":"What is the best practice in secondary prevention in 2020?","presenter":"Ulrich Laufs, Germany","photo":""},"playlist":[{"name":"Management of stable coronary heart disease patients","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/22\/Ulrich Laufs - EAS20 - 1448 - Management of stable coronary heart disease patients.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/22\/Ulrich Laufs - EAS20 - 1448 - Management of stable coronary heart disease patients.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/22\/7A439FF0.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Xi0qY"}
[session]
[presentation]
[presenter]
